Evidence map›Paper›PMID 24564169›Full record

ArticleBMC bioinformatics2013

Computational tools for copy number variation (CNV) detection using next-generation sequencing data: features and perspectives.

Min Zhao, Qingguo Wang, Quan Wang, Peilin Jia, Zhongming Zhao

Registry-linked trialAbstract read
In one paragraph

Article in BMC bioinformatics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02555969 (Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis), which is not on this map. Cited by 257 papers.

0numbers the graph read from it
0cells of the map it votes in
257citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02555969 completednot on this mapstarted 2015, after this paper: background citation

Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis

TypeobservationalSponsorTufts Medical CenterRan2015 to 2020Enrolled56ConditionsAmyloidosis, Primary Amyloidosis
3 · Its place in the literature

Who cites it

257 citing papers in PubMed.

  1. Review
  2. Article
  3. The Pan-Tumor Landscape of Gene Amplifications and Copy Number Amplification Ratio for Established and Emerging Clinical Targets.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Whole exome sequencing: a new era in prenatal diagnostics.Journal of translational medicine · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

197 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Min Zhao
Qingguo Wang
Quan Wang
Peilin Jia
Zhongming Zhao

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Understanding and Controlling p120 Dysfunction in CRCP50CA095103 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COFFEY, ROBERT J. · 2002 to 2017
$33.6M
Mapping the Genetic Architecture of Complex Disease via RNA-seq and GWAS DataR01LM011177 · NLM · VANDERBILT UNIVERSITY · PI ZHAO, ZHONGMING · 2012 to 2014
$1.0M
Integrative statistical models for pathway analysis of GWAS dataR21HG006037 · NHGRI · VANDERBILT UNIVERSITY · PI WANG, LILY, ZHAO, ZHONGMING · 2013 to 2014
$445k
NCI NIH HHS P30CA68485NCI NIH HHS P50CA095103NHGRI NIH HHS R21 HG006037NHGRI NIH HHS R21HG006037NLM NIH HHS R01LM011177
6 · The paper itself

Abstract

Copy number variation (CNV) is a prevalent form of critical genetic variation that leads to an abnormal number of copies of large genomic regions in a cell. Microarray-based comparative genome hybridization (arrayCGH) or genotyping arrays have been standard technologies to detect large regions subject to copy number changes in genomes until most recently high-resolution sequence data can be analyzed by next-generation sequencing (NGS). During the last several years, NGS-based analysis has been widely applied to identify CNVs in both healthy and diseased individuals. Correspondingly, the strong demand for NGS-based CNV analyses has fuelled development of numerous computational methods and tools for CNV detection. In this article, we review the recent advances in computational methods pertaining to CNV detection using whole genome and whole exome sequencing data. Additionally, we discuss their strengths and weaknesses and suggest directions for future development.

Indexed as

DNA Copy Number VariationsExonsGenomeGenomicsGenotypeHigh-Throughput Nucleotide SequencingHumans

Identifiers

PMID24564169
PMCPMC3846878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.